A Study Testing if Medicine Can Make Pigment Epithelium Detachments Regress and Stabilize the Vision in Eyes
Status:
Terminated
Trial end date:
2015-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine treatment effects in patients with retinal pigment
epithelium detachment (PED) in relation to Age Related Maculopathy (AMD). Patients with newly
diagnosed PED without choroidal neovascularisations (CNV), will be randomized to either
treatment or observation. The treatment group will first be given injections with anti
Vascular Endothelium Growth Factor (anti-VEGF). If the injections do not have any effect,
Verteporfin Photodynamic Therapy (PDT) will be given. All patients will be followed for a
period of 2 years. It is hypothesized that treatment stops the progression of the disease and
stabilizes the vision in this subgroup of patients with AMD.